Literature DB >> 7551342

Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasia.

M Kobayashi1, H Watanabe, Y Ajioka, M Yoshida, J Hitomi, H Asakura.   

Abstract

The wild-type p53 gene suppresses cell proliferation and induces apoptosis when it is transfected into human colon cancer cell lines. Therefore, mutation of the p53 gene, which correlates closely with p53 protein overexpression, would be predicted to activate cell proliferation and limit apoptosis. We tested this hypothesis by correlating p53 protein expression with cell proliferation and apoptosis in 70 neoplasms (29 adenomas and 41 carcinomas) using p53 and Ki-67 immunohistochemical staining and DNA nick end labelling. The p53 immunoreactivity was independent of the Ki-67 positivity. The apoptotic incidence was less frequent (P < 0.005) in tumours with diffuse p53 protein overexpression than in those with the sporadic overexpression, defined as p53 staining of isolated or scattered expression. In addition, apoptotic incidence only correlated directly (P < 0.05) with Ki-67 positivity in tumours with sporadic p53-protein expression. These results indicate that p53 protein that is expressed sporadically in colorectal neoplasms is probably wild-type protein and induces apoptosis in response to active cell proliferation. In contrast, diffusely overexpressed p53 protein in colorectal neoplasms is probably mutant and correlates with a reduction in apoptotic cell death independently of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551342     DOI: 10.1007/bf00203734

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Reduced apoptotic cell death in follicular lymphoma.

Authors:  K Hollowood; J C Macartney
Journal:  J Pathol       Date:  1991-04       Impact factor: 7.996

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  Apoptosis (cell death) induced in mouse bowel by 1,2-dimethylhydrazine, methylazoxymethanol acetate, and gamma-rays.

Authors:  K Ijiri
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

5.  p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder.

Authors:  Y Oohashi; H Watanabe; Y Ajioka; K Hatakeyama
Journal:  Pathol Int       Date:  1995-01       Impact factor: 2.534

6.  p53 protein accumulates frequently in early bronchial neoplasia.

Authors:  W P Bennett; T V Colby; W D Travis; A Borkowski; R T Jones; D P Lane; R A Metcalf; J M Samet; Y Takeshima; J R Gu
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

7.  Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.

Authors:  R Montironi; C Magi Galluzzi; M Scarpelli; I Giannulis; L Diamanti
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  6 in total

1.  Risk of recurrence after surgical resection of small-sized invasive lung adenocarcinoma: analysis based on apoptotic index.

Authors:  Atsushi Morio; Hideaki Miyamoto; Hiroshi Izumi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-07

2.  Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis.

Authors:  R Kushima; W Müller; M Stolte; F Borchard
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.

Authors:  K Matsuda; H Watanabe; Y Ajioka; M Kobayashi; H Saito; M Sasaki; K Yasuda; A Kuwabara; K Nishikura; T Muto
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

4.  Bcl-2 expression and frequency of apoptosis correlate with morphogenesis of colorectal neoplasia.

Authors:  Y Suzuki; T Honma; S Hayashi; Y Ajioka; H Asakura
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

5.  Growth dysregulation and p53 accumulation in human primary colorectal cancer.

Authors:  D S Watson; I Brotherick; B K Shenton; R G Wilson; F C Campbell
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

6.  Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo.

Authors:  M Ishida; Y Gomyo; S Ohfuji; M Ikeda; H Kawasaki; H Ito
Journal:  Jpn J Cancer Res       Date:  1997-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.